Literature DB >> 20498143

Vascular endothelial growth factor, soluble fms-like tyrosine kinase 1, and the severity of coronary artery disease.

Soo-Young Kim1, Sang-Hak Lee, Sungha Park, Seok-Min Kang, Namsik Chung, Won-Heum Shim, Seung-Yun Cho, Ichiro Manabe, Yangsoo Jang.   

Abstract

BACKGROUND: The association between vascular endothelial growth factor (VEGF), soluble fms-like tyrosine kinase 1 (sFlt-1), and coronary artery disease (CAD) was investigated.
METHODS: We enrolled 112 hypertensive patients with proven CAD and 112 hypertensive controls matched for age and gender. The severity of CAD was assessed by the most severe clinical presentation of CAD in patients' history and by the number of diseased vessels.
RESULTS: Vascular endothelial growth factor level was lower, whereas sFlt-1 level was higher in the CAD group compared to the controls. Diabetes mellitus (P = .001), smoking (P = .004), and higher sFlt-1 level (P = .01) were independently associated with CAD. Younger age (P = .02), smoking (P = .049), and higher VEGF levels (P = .02) were independently associated with a history of myocardial infarction (MI), whereas higher sFlt-1 level (P = .01) was independently associated with multivessel disease.
CONCLUSION: Plasma sFlt-1 levels are positively associated with the presence of CAD and are associated with angiographical severity of CAD.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20498143     DOI: 10.1177/0003319710370963

Source DB:  PubMed          Journal:  Angiology        ISSN: 0003-3197            Impact factor:   3.619


  5 in total

1.  Circulating angiogenic biomolecules at rest and in response to upper-limb exercise in individuals with spinal cord injury.

Authors:  Angelo V Vasiliadis; Andreas Zafeiridis; Konstantina Dipla; Nikiforos Galanis; Dimitrios Chatzidimitriou; Antonios Kyparos; Michalis G Nikolaidis; Ioannis S Vrabas
Journal:  J Spinal Cord Med       Date:  2013-11-26       Impact factor: 1.985

2.  Prognostic value of VEGF in patients submitted to percutaneous coronary intervention.

Authors:  Catarina Ramos; Patrícia Napoleão; Mafalda Selas; Cláudia Freixo; Ana Maria Viegas Crespo; Miguel Mota Carmo; Rui Cruz Ferreira; Teresa Pinheiro
Journal:  Dis Markers       Date:  2014-07-07       Impact factor: 3.434

3.  Angiogenic factors in women ten years after severe very early onset preeclampsia.

Authors:  Ingrid P M Gaugler-Senden; Jouke T Tamsma; Chris van der Bent; Ron Kusters; Eric A P Steegers; Christianne J M de Groot
Journal:  PLoS One       Date:  2012-08-31       Impact factor: 3.240

4.  Serum VEGF Predicts Worse Clinical Outcome of Patients with Coronary Heart Disease After Percutaneous Coronary Intervention Therapy.

Authors:  Xia Han; Lili Liu; Jiamin Niu; Jun Yang; Zengtang Zhang; Zhiqiang Zhang
Journal:  Med Sci Monit       Date:  2015-10-26

5.  Serum VEGF: Diagnostic Value of Acute Coronary Syndrome from Stable Angina Pectoris and Prognostic Value of Coronary Artery Disease.

Authors:  Anan Huang; Xin Qi; Yameng Cui; Yulin Wu; Shiqi Zhou; Mingyin Zhang
Journal:  Cardiol Res Pract       Date:  2020-01-10       Impact factor: 1.866

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.